Applying dried blood spot sampling with LCMS quantification in the clinical development phase of tasquinimod

被引:4
作者
Svensson, Leif D. [1 ]
Sennbro, Carl-Johan [2 ]
Svanstrom, Camilla [3 ]
Hansson, Gunnar P. [4 ]
机构
[1] Act Biotech AB, Lund, Sweden
[2] LEO Pharma, Ballerup, Denmark
[3] Repligen AB, Lund, Sweden
[4] IFKAN AB, Hassleholm, Sweden
关键词
BIOANALYSIS; DBS; HEMATOCRIT;
D O I
10.4155/bio.14.259
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Tasquinimod is an orally active anticancer drug in late clinical development. Here we describe the development and validation of a bioanalytical method based upon dried blood spot analysis in combination with LCMS/MS and stable isotope dilution. Results & discussion: The present method was validated for accuracy, precision, linearity, selectivity, carry-over and ruggedness. Data elucidating stability of tasquinimod in dried blood spots and in blood at ambient temperature was investigated and found adequate. Furthermore, in a clinical study, incurred samples reanalysis was performed, and the correlation of blood concentration versus plasma concentrations of tasquinimod was investigated. Conclusion: The method described here is suitable for bioanalysis of tasquinimod in whole blood from humans in clinical studies.
引用
收藏
页码:179 / 191
页数:13
相关论文
共 23 条
[11]   Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection [J].
Li, Fumin ;
Ploch, Stephen ;
Fast, Douglas ;
Michael, Steve .
JOURNAL OF MASS SPECTROMETRY, 2012, 47 (05) :655-667
[12]  
Meesters RJW, 2012, BIOANALYSIS, V4, P2027, DOI [10.4155/BIO.12.175, 10.4155/bio.12.175]
[13]   Direct quantification in bioanalytical LC-MS/MS using internal calibration via analyte/stable isotope ratio [J].
Nilsson, Lars B. ;
Eklund, Goran .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (03) :1094-1099
[14]   Investigation of absolute and relative response for three different liquid chromatography/tandem mass spectrometry systems; the impact of ionization and detection saturation [J].
Nilsson, Lars B. ;
Skansen, Patrik .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2012, 26 (12) :1399-1406
[15]   Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS [J].
Sadilkova, Katerina ;
Busby, Barbara ;
Dickerson, Jane A. ;
Rutledge, Joe C. ;
Jack, Rhona M. .
CLINICA CHIMICA ACTA, 2013, 421 :152-156
[16]   Dried blood spots: Concepts, present status, and future perspectives in bioanalysis [J].
Sharma, Abhisheak ;
Jaiswal, Swati ;
Shukla, Mahendra ;
Lal, Jawahar .
DRUG TESTING AND ANALYSIS, 2014, 6 (05) :399-414
[17]   Dried blood spot sampling for quantitative bioanalysis: time for a revolution? [J].
Spooner, Neil .
BIOANALYSIS, 2010, 2 (11) :1781-1781
[18]   Dried Blood Spots as a Sample Collection Technique for the Determination of Pharmacokinetics in Clinical Studies: Considerations for the Validation of a Quantitative Bioanalytical Method [J].
Spooner, Neil ;
Lad, Rakesh ;
Barfield, Matt .
ANALYTICAL CHEMISTRY, 2009, 81 (04) :1557-1563
[19]  
Svensson LD, 2013, BIOANALYSIS, V5, P2015, DOI [10.4155/BIO.13.158, 10.4155/bio.13.158]
[20]   Update of the EBF recommendation for the use of DBS in regulated bioanalysis integrating the conclusions from the EBF DBS-microsampling consortium [J].
Timmerman, Philip ;
White, Steve ;
Cobb, Zoe ;
de Vries, Ronald ;
Thomas, Elizabeth ;
van Baar, Ben .
BIOANALYSIS, 2013, 5 (17) :2129-2136